Format

Send to

Choose Destination
See comment in PubMed Commons below
Biotechnol Prog. 2013 Sep-Oct;29(5):1150-7. doi: 10.1002/btpr.1784. Epub 2013 Aug 28.

Active, soluble recombinant melittin purified by extracting insoluble lysate of Escherichia coli without denaturation.

Author information

1
Dept. of Biopharmaceutical Sciences, University of Illinois, Chicago, IL, 60612-7231.

Abstract

Cell lytic peptides are a class of drugs that can be used to selectively kill invading organisms or diseased cells. Several of these peptides have been identified as potential therapeutics. Herein, we report a novel process for purifying recombinant melittin, a cell lytic peptide that inserts into the membranes of cells causing cell lysis, from Escherichia coli. The process involves surfactant and low pH to solubilize melittin fusion proteins from the insoluble fraction of bacterial lysates. We are able to significantly improve purity of the final product and confirm the activity of the peptide. The process yields recombinant melittin that is effective when used to treat U-87 MG glioma cells and inhibits growth of the gram-positive pathogenic bacterium Streptococcus pyogenes. We demonstrate a method of repeated extraction of the insoluble protein fraction with mild detergent at a low pH that is able to generate a yield of pure, soluble melittin of ∼ 0.5-1 mg/L of E. coli culture.

KEYWORDS:

fusion protein; melittin; protein extraction; recombinant protein; surfactant

PMID:
23926061
PMCID:
PMC3874069
DOI:
10.1002/btpr.1784
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center